Global Expert Consensus Standardizes Ultrasound-Derived Fat Fraction for Noninvasive Fatty Liver Quantification and Metabolic Monitoring

Fudan University researchers establish a clinical consensus for UDFF, a low-cost, high-accuracy ultrasound tool for grading liver steatosis in MASLD patients.

By: AXL Media

Published: Mar 17, 2026, 7:16 AM EDT

Source: Information for this report was sourced from Chinese Medical Journals Publishing House Co., Ltd.

Addressing the Global MASLD Crisis

The rapid increase in obesity, type 2 diabetes, and metabolic syndrome has propelled fatty liver disease to the forefront of chronic health challenges worldwide. Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, steatohepatitis (MASH), now require precise quantification to guide clinical intervention and monitor therapeutic responses. While liver biopsy has historically served as the diagnostic benchmark, its invasive nature and susceptibility to sampling errors have created an urgent demand for reliable noninvasive alternatives. According to Dr. Huixiong Xu and Dr. Hong Ding, ultrasound-derived fat fraction (UDFF) has emerged as a transformative tool that combines the accessibility of bedside imaging with the objective accuracy of advanced diagnostics.

Standardizing the Quantitative Platform

To bridge the gap between experimental research and routine clinical use, an expert consensus was published on March 6, 2026, to standardize UDFF protocols. This initiative synthesized data from extensive multicenter trials and biopsy-based validation studies to provide a unified framework for practitioners. Unlike conventional ultrasound, which relies on subjective visual grading, UDFF provides a localized, quantitative percentage of hepatic fat content. This shift toward objectivity allows for more consistent longitudinal tracking of patients, ensuring that changes in liver fat are measured with scientific rigor rather than clinician intuition.

Validation Against Gold Standard Modalities

The reliability of UDFF has been rigorously tested against high-cost imaging standards such as magnetic resonance imaging-derived proton density fat fraction (MRI-PDFF) and proton magnetic resonance spectroscopy. In a comprehensive meta-analysis of 1,150 patients, UDFF demonstrated a pooled sensitivity of 90.4% and an exceptional diagnostic accuracy, frequently outperforming traditional serological indices and controlled attenuation parameters. The study confirmed that intra-operator and inter-operator reproducibility remained high, with correlation coefficients exceeding 0.94. These results suggest that UDFF can serve as a scalable surrogate for MRI in environments where cost and equipment availability are significant barriers.